Compare OBK & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | PRCT |
|---|---|---|
| Founded | 1912 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2018 | 2021 |
| Metric | OBK | PRCT |
|---|---|---|
| Price | $54.43 | $20.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $46.67 | $35.44 |
| AVG Volume (30 Days) | 149.9K | ★ 930.8K |
| Earning Date | 04-22-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ 1.97 | N/A |
| Revenue | N/A | ★ $308,054,000.00 |
| Revenue This Year | $26.43 | $31.34 |
| Revenue Next Year | $5.79 | $24.52 |
| P/E Ratio | $27.22 | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $32.13 | $16.67 |
| 52 Week High | $55.57 | $40.10 |
| Indicator | OBK | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | 45.20 |
| Support Level | $52.46 | $19.87 |
| Resistance Level | $55.29 | $29.27 |
| Average True Range (ATR) | 0.84 | 1.04 |
| MACD | 0.02 | -0.12 |
| Stochastic Oscillator | 63.20 | 10.08 |
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.